Literature DB >> 17163841

Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies.

P Mhawech-Fauceglia1, F Herrmann, R Penetrante, A Beck, S Sait, A M Block, K Odunsi, J Fisher, L Balos, R T Cheney.   

Abstract

AIMS: To compare the sensitivity and specificity of the recently commercially available FLI-1 monoclonal (FLI-1m) antibody with the currently used antibodies [CD99 and FLI-1 polyclonal (FLI-1p)] in the diagnosis of Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET) and to determine the diagnostic value of the EWSR1 (22q12) dual-colour, break-apart rearrangement probe fluorescence in situ hybridization (FISH) technique.
MATERIALS AND METHODS: Forty-three cases of well-documented EWS/PNET and 15 non-EWS/PNET cases were retrieved from the archival files. Immunohistochemistry (IHC) for FLI-1p, FLI-1m and FISH analysis was performed.
RESULTS: The most sensitive and specific test panel for the diagnosis of EWS/PNET is the combination of CD99 and FLI-1p. FISH had a very high specificity (100%) but only a moderate sensitivity (50%).
CONCLUSION: The combination of CD99 and FLI-1p is the method of choice for the diagnosis of EWS/PNET. EWRS1 (22q12) dual-colour, break-apart rearrangement probe FISH should be used as a confirmatory test in addition to CD99 and FLI1-p due to its high specificity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17163841     DOI: 10.1111/j.1365-2559.2006.02535.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  24 in total

Review 1.  [Value of core needle biopsy in preoperative diagnostics of soft tissue tumors: possibilities and limitations].

Authors:  A Agaimy
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

2.  Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support.

Authors:  Antonio Llombart-Bosch; Isidro Machado; Samuel Navarro; Franco Bertoni; Patrizia Bacchini; Marco Alberghini; Apollon Karzeladze; Nikita Savelov; Semyon Petrov; Isabel Alvarado-Cabrero; Doina Mihaila; Philippe Terrier; Jose Antonio Lopez-Guerrero; Piero Picci
Journal:  Virchows Arch       Date:  2009-10-17       Impact factor: 4.064

3.  The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.

Authors:  Ciğdem Vural; Omer Uluoğlu; Nalan Akyürek; Aynur Oğuz; Ceyda Karadeniz
Journal:  Pathol Oncol Res       Date:  2011-01-26       Impact factor: 3.201

Review 4.  Ewing sarcoma/peripheral primitive neuroectodermal tumor and related tumors.

Authors:  Maria Tsokos; Rita D Alaggio; Louis P Dehner; Paul S Dickman
Journal:  Pediatr Dev Pathol       Date:  2012

5.  Clinical presentation and long-term outcome of primary spinal peripheral primitive neuroectodermal tumors.

Authors:  Xianzeng Tong; Xiaofeng Deng; Tao Yang; Chenlong Yang; Liang Wu; Jun Wu; Yuqiang Yao; Zhuang Fu; Shuo Wang; Yulun Xu
Journal:  J Neurooncol       Date:  2015-07-18       Impact factor: 4.130

6.  Primary Ewing's Sarcoma/Primitive Neuroectodermal Tumour of the Cervix: a Rare Tumour.

Authors:  Vikas Gupta; K V V N Raju; D Sridhar; Syed Murtaza Ahmed; Daphne Fonseca
Journal:  Indian J Surg Oncol       Date:  2019-08-16

7.  Uterine tumors with neuroectodermal differentiation. A report of 4 cases.

Authors:  Pavel Dundr; Daniela Fischerová; Ctibor Povýšil; Adéla Berková; Lenka Bauerová; David Cibula
Journal:  Pathol Oncol Res       Date:  2010-03-05       Impact factor: 3.201

8.  Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases.

Authors:  Bharat Rekhi; Ulrich Vogel; Ranjan Basak; Sangeeta B Desai; Nirmala A Jambhekar
Journal:  Pathol Oncol Res       Date:  2013-11-30       Impact factor: 3.201

9.  The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma.

Authors:  Ryo Shibuya; Atsuji Matsuyama; Mitsuhiro Nakamoto; Eisuke Shiba; Takahiko Kasai; Masanori Hisaoka
Journal:  Virchows Arch       Date:  2014-07-17       Impact factor: 4.064

10.  Advantage of FISH analysis using FKHR probes for an adjunct to diagnosis of rhabdomyosarcomas.

Authors:  Tadaki Matsumura; Takehiko Yamaguchi; Kunihiko Seki; Tadakazu Shimoda; Takuro Wada; Toshihiko Yamashita; Tadashi Hasegawa
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.